Mike Wardach

Astatine-211 offers significant advantages for smaller organic molecules due to its similarity to iodine in chemistry, eliminating the need for a chelator. This makes it easier to attach to drug-like molecules without altering their ability to bind to targets, unlike metal-based conjugates that often face challenges with chelator incorporation. While the supply of astatine is theoretically unlimited, niche cyclotron technologies affect availability.

Join this workshop for the opportunity to:

• Explore 211At decay properties to overcome toxicities
• Unlocking 211At conjugation chemistry and assessing prime biological targeting vectors, strategies, and targets
• Investigating potential of astatine development to industry-sponsored clinical trials